论文部分内容阅读
本文主要选择23名育龄,不愿再孕的健康妇女。通过采用六个不同组的Pr-β-hCG-TT疫苗所产生的抗体反应给予一定的评价,见下表所示: 实验结果指出Pr-β-hCG-TT疫苗使大部份人产生了免疫作用。在第一次注射4～6个月后产生抗体试验高峰,但大多数不能持久。大部份人示一尖锐峰,一人无反应,二人是低反应。在结合试验中加用3mgSPLPS的一组似乎更有希望。同种疫苗对不同人和不同的疫苗所发生的最高
This article mainly selects 23 healthy women who are unwilling to conceive again. The antibody responses produced by the six different groups of Pr-β-hCG-TT vaccines gave some estimates, as shown in the table below: The experimental results indicate that the Pr-β-hCG-TT vaccine produced immunity to most humans effect. Antibody tests peak after 4 to 6 months of first injection, but most do not last long. Most people show a sharp peak, one without response, two are low response. A group that used 3 mg SPLPS in combination trials seemed to be more promising. The same vaccines have the highest incidence on different people and on different vaccines